Procter & Gamble Hygiene & Healthcare Ltd. - Research Center
500459 PGHH Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Jun ' 24 | Jun ' 23 | Jun ' 22 | Jun ' 21 | Jun ' 20 | |
|---|---|---|---|---|---|
| Sales | 4,205.70 | 3,917.90 | 3,900.92 | 3,574.14 | 3,001.99 |
| Operating profit | 970.23 | 868.63 | 829.89 | 884.28 | 603.71 |
| Interest | 26.78 | 11.38 | 11.19 | 6.11 | 6.07 |
| Gross profit | 995.70 | 897.83 | 843.02 | 917.55 | 641.75 |
| EPS (Rs) | 207.95 | 208.92 | 177.37 | 200.80 | 133.42 |
Annual
results in details
| Jun ' 24 | Jun ' 23 | Jun ' 22 | Jun ' 21 | Jun ' 20 | |
|---|---|---|---|---|---|
| Other income | 52.25 | 40.58 | 24.32 | 39.38 | 44.11 |
| Stock adjustment | -12.13 | -8.53 | -6.50 | -10.22 | -7.82 |
| Raw material | 771.94 | 847.55 | 1,260.34 | 1,128.39 | 1,066.21 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 245.64 | 205.79 | 214.34 | 201.68 | 173.29 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | 426.52 | 471.24 | 522.48 | 328.30 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 2,230.02 | 1,577.94 | 1,131.61 | 839.89 | 824.42 |
| Provisions made | - | - | - | 7.64 | 13.88 |
| Depreciation | 56.50 | 58.36 | 52.88 | 47.66 | 47.88 |
| Taxation | 264.18 | 161.33 | 214.39 | 218.10 | 160.79 |
| Net profit / loss | 675.02 | 678.14 | 575.75 | 651.79 | 433.08 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 32.46 | 32.46 | 32.46 | 32.46 | 32.46 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.07 | 22.17 | 21.27 | 24.74 | 20.11 |
| GPM (%) | 23.38 | 22.68 | 21.48 | 25.39 | 21.07 |
| NPM (%) | 15.85 | 17.13 | 14.67 | 18.04 | 14.22 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis